United States · FDA National Drug Code directory
Nalbuphine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70069-672_d7e3d7be-ce38-4696-979c-64dd1023a4cd
- Product NDC
- 70069-672
- Form
- INJECTION
- Composition / generic term
- Nalbuphine hydrochloride
- Labeler
- Somerset Therapeutics, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240925
- Source listing expiry
- 20261231
Source-listed ingredients
- NALBUPHINE HYDROCHLORIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 AMPULE in 1 CARTON (70069-672-10) / 1 mL in 1 AMPULE (70069-672-01) · 70069-672-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →